Hemostasis and Common Bleeding Disorders Flashcards
3 main players in bleeding disorders pathophys
Blood vessel wall
Platelets and vWF
Coagulation factors
4 main processes to get a clot
Primary hemostasis
Secondary hemostasis
Termination of clotting
Fibrinolysis
Primary hemostasis
Initial response to stop bleeding
Forms the primary platelet plug
vWF can bind to the exposed subendothelium and start to elongate to grab the platelets and activate them
Secondary hemostasis
Propagation of the clotting process
Involves interaction of coagulation factors on platelet plug
Activated platelets provide a good surface for the coag factors to be activated
Endpoint is a stable fibrin clot
What is the main protein created at the end of the coag cascade?
Thrombin
Is a 1. Vessel problem 2. Platelet of vWF problem 3. Coag factor problem due to primary or secondary hemostasis
- Primary
- Primary
- Secondary
What coag factor is attached to vWF?
Factor 8
Acquired Senile Purpura
Vessel problem
Age dependent deterioration of the vasculature supporting structure
Bruising on the dorsum of the hands and forearms
Serious bleeding does not occur
Von Willebrand Disease
Caused by inherited defects in the concentration, structure or function of vWF
Mostly autosomal dominant with variable penetrance
3 types of vWF disease
Type 1: decreased amount of vWF (common). Mucocutaneous bleeding
Type 2: dysfunctional vWF protein (uncommon). Mucocutaneous bleeding
Type 3: no vWF protein. Associated decreased factor 8 because vWF is the carrier (rare). Severe mucocutaneous bleeding, can see joint/muscle bleeding
Hemophilia (what 2 types)
Inherited bleeding disorder with a mild, moderate or severe deficiency of a coagulation factor
A: factor 8 deficiency (more common)
B: factor 9 deficiency
X linked recessive so seen more commonly in males
3 causes of acquired coagulation factor problems
Liver disease (lack of production) Anticoagulants (bleeding with overdose, trauma, or procedures) Vitamin K deficiency (several proteins need vit K as a cofactor)
Key questions on a clinical bleeding history
Is the bleeding musculocutaneous, soft-tissue or joint?
One or multiple sites?
Inherited or acquired?
Severity (spontaneous/provoked, treated/not)
PTT
Partial thromboplastin time
Assesses intrinsic and common pathway
PT
Prothrombin time (INR) Assesses extrinsic and common pathway